通过CYP2C19的药物遗传学测试,优化小儿异性食道炎中的质子抑制剂治疗
Sierra Scodellaro1, Kristen A Bortolin2, Margaret A Marcon2,3
1Department of Paediatrics, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Journal of the Canadian Association of Gastroenterology
|June 26, 2025
概括
在性食道炎 (EoE) 患者中,针对CYP2C19代谢器状态的药物遗传学测试可以指导质子抑制剂 (PPI) 治疗. 识别快速或超快速代谢剂有助于优化PPI剂量,改善治疗结果和缓解率.
科学领域:
- 胃肠病学 胃肠病学
- 药物基因组学 药物基因组学
- 儿科医学 儿科医学
背景情况:
- 生性食道炎 (EoE) 是一种慢性炎症状况,使用质子抑制剂 (PPI) 治疗.
- 在CYP2C19的遗传变异影响PPI的疗效和副作用.
- 药物遗传学 (PGx) 测试可以预测PPI反应,但临床实施缓慢.
研究的目的:
- 调查CYP2C19药物遗传测试对儿科EOE患者PPI管理的影响.
- 为了将PGx结果与PPI疗效和EOE中的组织学结果相关联.
主要方法:
- 对儿科EoE患者进行了一项前性队列研究.
- 患者接受了CYP2C19的PGx测试.
- 通过内镜活检评估了PPI使用和组织学结果.
主要成果:
- 69名患者中有29%是快速代谢者,7%是超快速代谢者.
- 在64%的患者中,进行了PGx引导的管理变化.
- 49%的患者实现了组织学缓解,其中40%的患者对PGx引导治疗有反应.
结论:
- 由于快速/超快速的CYP2C19代谢,不适当的PPI剂量可能会导致EoE没有反应.
- 在儿科EOE患者中确定CYP2C19状态引导治疗变化并改善缓解率.
- 应考虑在EoE中进行个性化PPI治疗时进行例行PGx测试.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
312
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
312
Gastroesophageal Reflux Disease II: Clinical Features and Management
221
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
221
Peptic Ulcer Disease IV: Management
150
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
150
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
534
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
534
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
560
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
560
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
574
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
574


